Retrospective Analysis of Adoptive TIL Therapy plus Anti-PD1 Therapy in Patients with Chemotherapy-Resistant Metastatic Osteosarcoma

Table 5

Multivariate analysis (mPFS).

Parameters	Hazard ratio	95% confidence interval	value
Infusion of CD8^+TIL numbers ( vs. )	3.73	(2.11, 6.57)	<0.0001
Infusion of CD8^+TIL percentage (≥60% vs. <60%)	4.05	(2.15, 7.64)	<0.0001
Infusion of CD8^+PD1^+TIL percentage (≥10% vs. <10%)	2.98	(1.57, 5.66)	<0.0001
Infusion of CD4^+FoxP3^+TIL percentage (≥20% vs. <20%)	3.12	(1.98, 5.78)	<0.0001